원격 환자 모니터링 소프트웨어 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the remote patient monitoring software market size was valued at USD 15.66 billion in 2025 and is estimated to grow from USD 20.73 billion in 2026 to reach USD 84.17 billion by 2031, at a CAGR of 32.35% during the forecast period (2026-2031).

This report is Segmented by Offering (Software, Devices, Services), Deployment (Cloud, On-Premises, Hybrid), Application (Cardiovascular, Diabetes, Respiratory, Oncology, Others), Data Type (BP, Glucose, Spo2, ECG, Others), End User (Hospitals, Ambulatory, Physicians, Home Healthcare, Others), and Geography (North America, Europe, Asia-Pacific, MEA, South America). Forecasts in Value (USD).

Global Remote Patient Monitoring Software Market Trends and Insights

Rising Adoption of Value-Based Care

Value-based payment models increased the need for continuous patient data, as providers had to demonstrate outcomes rather than only document activity. CMS launched the ACCESS Model on July 5, 2026, as a voluntary 10-year program for chronic-condition care. Outcome-Aligned Payments required providers to meet guideline-based targets for enrolled patients, increasing the value of software that tracked health measures over time. The model positioned the remote patient monitoring software market closer to a core care-management function within participating organizations, while the 2026 ACO REACH cycle also supported virtual and remote monitoring for quality performance.

Shorter-Interval Monitoring Enabling New Reimbursement Pathways

The CMS CY 2026 Physician Fee Schedule final rule expanded the reimbursement structure for the remote patient monitoring software market. The rule introduced CPT 99445 for device supply with 2 to 15 days of data transmission and CPT 99470 for the first 10 minutes of treatment management. CPT 99445 paid USD 52.11 per month, while CPT 99470 paid USD 26.05 per month, removing the prior 16-day threshold that excluded many older, cognitively impaired, post-acute, and less adherent patients. A practice enrolling 500 newly eligible patients could generate USD 39,000 in monthly revenue from these two codes, while Germany had 64 approved DiGA applications by the end of 2025, with more than EUR 125 million in statutory insurance reimbursements, equal to USD 137 million at the 2025 average exchange rate.

Cybersecurity, Privacy, and Data-Localization Exposure

Remote monitoring systems create broad exposure because they continuously transmit and store patient data. HHS proposed major updates to the HIPAA Security Rule on January 6, 2025, including multifactor authentication, encryption, network segmentation, and vulnerability scans at least twice a year. These requirements can increase operating costs for smaller vendors that lack established security capabilities. European health data portability rules and country-level hosting requirements add complexity, and platforms designed for the U.S. cloud environment may require substantial redesign to serve Germany or France, extending entry timelines by 12 to 24 months and reducing global deployment efficiency.

Other drivers and restraints analyzed in the detailed report include:

1. Increasing Chronic Disease Burden and Aging Population
2. Advances in Connected Sensors and AI-Based Risk Stratification
3. Alert Fatigue and Clinician Workflow Burden

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Software held 63.22% of the remote patient monitoring software market size in 2025, supported by earlier investments in platform infrastructure across U.S. hospitals, payer programs, and European reimbursement pilots. Services are projected to grow at a CAGR of 33.93% through 2031. Growth in the remote patient monitoring software market is shifting toward managed-service contracts, where vendors operate programs for health systems.

A software-only contract generally follows a per-patient subscription model, while managed-service arrangements combine licensing with clinical and operational support. This structure can increase total contract value by 2 to 3 times. Providers adopting outcome-based care models may prefer vendors that can deliver round-the-clock clinical support. As a result, the remote patient monitoring software industry is seeing stronger demand for integrated operating capabilities than for stand-alone licenses.

Cloud-based deployment held 58.77% of the remote patient monitoring software market size in 2025. Hospitals use cloud systems to scale capacity, receive regular updates, and manage large data volumes. Hybrid deployment is projected to grow at a CAGR of 34.86% through 2031, as health systems seek cloud flexibility while maintaining control over sensitive patient information.

Oracle Health ended support for FHIR DSTU2 in Cerner by December 2025 and moved customers toward FHIR R4. This shift supports hybrid models for hospitals that still operate on-premises HL7 v2 systems while using modern APIs for remote monitoring data. On-premises systems continue to serve high-security government and military settings and remain relevant where real-time cardiac monitoring cannot tolerate network delays. France's 2026-2028 telemedicine roadmap required integration with the national electronic health record environment, supporting modular systems that combine edge processing, cloud analysis, and local storage.

Complete Report Scope:

• By Offering
  • Software
  • Devices With Embedded Software
  • Services
• By Software Deployment
  • Cloud-Based
  • On-Premises
  • Hybrid
• By Application and Indication
  • Cardiovascular Disease
  • Diabetes Management
  • Respiratory and Pulmonary Disorders
  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Oncology
  • Others
• By Data Type
  • Blood Pressure
  • Blood Glucose
  • Weight
  • Oxygen Saturation
  • Heart Rate and Electrocardiogram
  • Temperature
  • Respiratory Rate
  • Activity, Mobility and Sleep Data
  • Others
• By End User
  • Healthcare Providers
  • Hospitals and Health Systems
  • Ambulatory Care Centers
  • Physician Practices
  • Home Healthcare Providers
  • Long-Term Care and Assisted Living Facilities
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 42.76% of the remote patient monitoring software market share in 2025, supported by Medicare coverage, integrated delivery networks, and established billing structures. The United States remained the largest regional contributor, backed by the 10-year ACCESS Model for chronic-condition care. Canada developed provincial telehealth reimbursement programs, although coverage varied by province. Mexico remained at an earlier stage, with private hospital networks in Monterrey and Mexico City deploying remote monitoring through employer-sponsored insurance offerings.

Europe relied on country-specific reimbursement systems, which made deployment more complex. Germany began rolling out its opt-out electronic patient record in January 2025, creating a national health-data framework to improve data exchange. The Hospital Future Fund supported cybersecurity and interoperability improvements across 1,900 German hospitals. France adopted its 2026 Social Security Finance Act in December 2025, linking some digital health financing to documented savings for Assurance Maladie. Asia-Pacific is forecast to grow at a CAGR of 34.56% through 2031, led by digital health activity in China, India, Japan, and South Korea.

The Middle East and Africa developed from a smaller base, supported by smart-hospital investments in the Gulf states and the UAE's digital health strategy. South Africa and selected francophone African countries emerged as users of hybrid systems operating through mobile networks. Brazil and Argentina led South America, where private health operators were key purchasers. Brazil's ANVISA framework and Argentina's private insurance groups served as central entry points for suppliers, while reimbursement precedent, infrastructure investment, and regulatory maturity will determine adoption through 2031.

1. Abbott Laboratories
2. American Well
3. Baxter
4. BioIntelliSense, Inc.
5. Boston Scientific
6. CareSimple Inc.
7. Dexcom
8. GE HealthCare Technologies Inc.
9. Health Recovery Solutions, Inc.
10. Koninklijke Philips
11. Medtronic
12. Nihon Kohden
13. OMRON Healthcare, Inc.
14. Optum
15. Oracle
16. Siemens Healthineers
17. Teladoc Health
18. Validic Inc.
19. VitalConnect, Inc.
20. VivaLNK, Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Adoption of Value-Based Care
  • 4.2.2 Expansion of Home-Based and Hospital-at-Home Care
  • 4.2.3 Increasing Chronic Disease Burden and Aging Population
  • 4.2.4 Advances in Connected Sensors and AI-Based Risk Stratification
  • 4.2.5 Interoperability-Driven Consolidation of Fragmented Patient Data
  • 4.2.6 Shorter-Interval Monitoring Enabling New Reimbursement Pathways
• 4.3 Market Restraints
  • 4.3.1 Fragmented Reimbursement and Billing Requirements
  • 4.3.2 Cybersecurity, Privacy and Data-Localization Exposure
  • 4.3.3 Alert Fatigue and Clinician Workflow Burden
  • 4.3.4 Inconsistent Clinical Evidence Across Patient Groups
• 4.4 Value/Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Rivalry Among Existing Competitors

5 MARKET SIZE AND GROWTH FORECASTS (VALUE, USD)

• 5.1 By Offering
  • 5.1.1 Software
  • 5.1.2 Devices With Embedded Software
  • 5.1.3 Services
• 5.2 By Software Deployment
  • 5.2.1 Cloud-Based
  • 5.2.2 On-Premises
  • 5.2.3 Hybrid
• 5.3 By Application and Indication
  • 5.3.1 Cardiovascular Disease
  • 5.3.2 Diabetes Management
  • 5.3.3 Respiratory and Pulmonary Disorders
  • 5.3.4 Chronic Obstructive Pulmonary Disease
  • 5.3.5 Asthma
  • 5.3.6 Oncology
  • 5.3.7 Others
• 5.4 By Data Type
  • 5.4.1 Blood Pressure
  • 5.4.2 Blood Glucose
  • 5.4.3 Weight
  • 5.4.4 Oxygen Saturation
  • 5.4.5 Heart Rate and Electrocardiogram
  • 5.4.6 Temperature
  • 5.4.7 Respiratory Rate
  • 5.4.8 Activity, Mobility and Sleep Data
  • 5.4.9 Others
• 5.5 By End User
  • 5.5.1 Healthcare Providers
  • 5.5.2 Hospitals and Health Systems
  • 5.5.3 Ambulatory Care Centers
  • 5.5.4 Physician Practices
  • 5.5.5 Home Healthcare Providers
  • 5.5.6 Long-Term Care and Assisted Living Facilities
  • 5.5.7 Others
• 5.6 By Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 India
    • 5.6.3.3 Japan
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.3.1 Abbott Laboratories
  • 6.3.2 American Well Corporation
  • 6.3.3 Baxter International Inc.
  • 6.3.4 BioIntelliSense, Inc.
  • 6.3.5 Boston Scientific Corporation
  • 6.3.6 CareSimple Inc.
  • 6.3.7 DexCom, Inc.
  • 6.3.8 GE HealthCare Technologies Inc.
  • 6.3.9 Health Recovery Solutions, Inc.
  • 6.3.10 Koninklijke Philips N.V.
  • 6.3.11 Medtronic plc
  • 6.3.12 NIHON KOHDEN CORPORATION
  • 6.3.13 OMRON Healthcare, Inc.
  • 6.3.14 Optum, Inc.
  • 6.3.15 Oracle Corporation
  • 6.3.16 Siemens Healthineers AG
  • 6.3.17 Teladoc Health, Inc.
  • 6.3.18 Validic Inc.
  • 6.3.19 VitalConnect, Inc.
  • 6.3.20 VivaLNK, Inc.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-Space and Unmet-Need Assessment